Advertisement
Advertisement
U.S. markets close in 4 hours 43 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Flexion Therapeutics, Inc. (FLXN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
9.35+0.03 (+0.38%)
As of 11:16AM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close9.31
Open9.30
Bid9.35 x 800
Ask9.36 x 900
Day's Range9.30 - 9.42
52 Week Range4.30 - 13.66
Volume189,918
Avg. Volume1,782,667
Market Cap470.244M
Beta (5Y Monthly)1.31
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for FLXN

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Flexion Therapeutics, Inc.
    Analyst Report: Eli Lilly and CompanyEli Lilly is a drug firm with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
    Rating
    Fair Value
    Economic Moat
    16 hours agoMorningstar
View more
Advertisement
Advertisement